Characteristics of Giant Cell Tumor of the Bone in Pediatric Patients: Our 18-Year, Single-Center Experience

被引:2
作者
Kim, Woo-Jong [1 ]
Kim, Sungmin [1 ]
Choi, Dae-Woong [1 ]
Lim, Gil-Hwan [1 ]
Jung, Sung-Taek [1 ]
机构
[1] Chonnam Natl Univ, Med Sch & Hosp, Dept Orthoped Surg, Gwangju 61469, South Korea
来源
CHILDREN-BASEL | 2021年 / 8卷 / 12期
关键词
giant cell tumor; pediatric patients; CLINICOPATHOLOGICAL ANALYSIS; LONG BONES; CURETTAGE; CHILDREN;
D O I
10.3390/children8121157
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
A giant cell tumor (GCT) of the bone is characteristically found in skeletally mature patients. The tumor is rare in pediatric patients, and incidence reported in literature varies from 1.8% to 10.6%. We performed a retrospective study addressing symptoms, treatment, and outcome in pediatric patients who were diagnosed with GCT between March 1997 and January 2015 at our hospital. Fourteen (11.1%) of 126 surgically treated patients with histologically proven GCT were <19 years of age. We confirmed skeletal maturity using magnetic resonance imaging (MRI). Fourteen patients from 8 to 19 years old were identified. Sixteen lesions (76.2%) were found in long bones and 5 lesions (23.8%) in short bones. The most common site was around the knee in 8 patients (38%). GCTs mostly occur at the epi-metaphysis in 11 patients (52.3%). Regardless of the openness of epiphyseal plate, we observed GCT of bone in the epiphysis. Further study will be needed to prove the association between the presence of epiphyseal plate and location of tumor. Three patients (21.4%) had multicentric lesions, and four patients (28.5%) had local recurrence. Multicentric giant cell tumor and local recurrence occur more often in pediatric patients. The characteristics of GCT in pediatric patients do not differ from what is reported for GCT in adults.
引用
收藏
页数:8
相关论文
共 28 条
[1]   Giant Cell Tumor of Bone in Patients under 16 Years Old: A Single-Institution Case Series [J].
Ambrosi, Francesca ;
Righi, Alberto ;
Benini, Stefania ;
Magagnoli, Giovanna ;
Chiaramonte, Ilaria ;
Manfrini, Marco ;
Gasbarrini, Alessandro ;
Frisoni, Tommaso ;
Gambarotti, Marco .
CANCERS, 2021, 13 (11)
[2]  
Board W.C.O.T.E, 2020, SOFT TISSUE BONE TUM
[3]   Denosumab: an Emerging Therapy in Pediatric Bone Disorders [J].
Boyce, Alison M. .
CURRENT OSTEOPOROSIS REPORTS, 2017, 15 (04) :283-292
[4]   GIANT-CELL TUMOR OF BONE - CHROMOSOMAL ANALYSIS OF 48 SPECIMENS AND REVIEW OF THE LITERATURE [J].
BRIDGE, JA ;
NEFF, JR ;
MOURON, BJ .
CANCER GENETICS AND CYTOGENETICS, 1992, 58 (01) :2-13
[5]   GIANT-CELL TUMOR OF BONE [J].
CAMPANACCI, M ;
BALDINI, N ;
BORIANI, S ;
SUDANESE, A .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1987, 69A (01) :106-114
[6]  
Campanacci M, 1975, Chir Organi Mov, V62, P29
[7]   Identification of Potential Biomarkers for Giant Cell Tumor of Bone Using Comparative Proteomics Analysis [J].
Conti, Amalia ;
Caballero Rodriguez, Gemma ;
Chiechi, Antonella ;
Degano Blazquez, Rosa Maria ;
Barbado, Victoria ;
Krenacs, Tibor ;
Novello, Chiara ;
Pazzaglia, Laura ;
Quattrini, Irene ;
Zanella, Licciana ;
Picci, Piero ;
De Alava, Enrique ;
Benassi, Maria Serena .
AMERICAN JOURNAL OF PATHOLOGY, 2011, 178 (01) :88-97
[8]   GIANT-CELL TUMOR OF BONE - HIGHLIGHTS OF 407 CASES [J].
DAHLIN, DC .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1985, 144 (05) :955-960
[9]  
DAHLIN DC, 1970, CANCER, V25, P1061, DOI 10.1002/1097-0142(197005)25:5<1061::AID-CNCR2820250509>3.0.CO
[10]  
2-E